Skip to main content
. 2023 Nov 15;16:2447–2458. doi: 10.2147/RMHP.S436750

Figure 2.

Figure 2

Tornado diagram of one-way sensitivity analyses of tislelizumab plus chemotherapy versus placebo plus chemotherapy in order of magnitude of the association.